Advertisement

Topics

Companies Related to "BIOSIMILARS Market Study Regulatory Framework Pipeline Analysis 2015" [Most Relevant Company Matches] RSS

02:51 EDT 19th September 2018 | BioPortfolio

Here are the most relevant search results for "BIOSIMILARS Market Study Regulatory Framework Pipeline Analysis 2015" found in our extensive corporate database of over 50,000 company records.

Showing "BIOSIMILARS Market Study Regulatory Framework Pipeline Analysis 2015" Companies 1–25 of 7,100+

Relevant

AAM Biosimilars Council

The Biosimilars Council, a division of the Association for Accessible Medicines (AAM), works to ensure a positive environment for patient access to biosimilar medicines. The Biosimilars Council is a leading source for information about the safety and efficacy of more affordable alternatives to costly brand biologic medicines. Areas of focus include public ...


FINOX AG

FINOX pioneers niche Biosimilars and wants to establish itself as a respected competitor in these markets. Through our Biosimilars to come we aim to create value for patients, partners and the investors: * for patients - with safe, efficient, easy-to-apply and fair priced therapies of highest quality * for partners and investors - with transparent partnerships of mutual ben...

Applied Logic Associates

Applied Logic Associates, Inc. (ALA) is a consulting firm for pharmaceutical, medical device and biotechnology companies in the areas of Clinical/Regulatory Affairs, Clinical Study Management, Information Management, Biostatistical Analysis and Health Care Economics. For 10 years, ALA has served as a vital link in bringing new products to market. ALA provides cost-effective and timely services fro...


Synteract Incorporated

ServicesBiostatistics/Data Analysis Programming and statistical analysis are completed using SAS software. Clinical Operations Data Management Electronic Regulatory Submissions Medical Writing Synteract can provide medical writing services for clinical protocols, INDs, clinical study reports, NDA sections and standard operating procedures. Regulatory Affairs Internet Access Services

The Center for Biosimilars

The Center for Biosimilars® is a digital resource that serves as a platform for health economic experts, managed care professionals, key clinical specialists and other authoritative industry voices, to share information on emerging technologies, with a focus on improving critical thinking in the field to affect patient outcomes. The Center for Bi...

Vivus

VIVUS, Inc. is a pharmaceutical company dedicated to the development and commercialization of next-generation therapeutic products addressing obesity and sexual health. Analysts speculate that the potential market for obesity ranges from $5 billion to $10 billion annually, and the indications targeted by VIVUS' sexual health products each represent a projected market greater than $1 billion annual...

Kronos Communicated Data Inc.

Formed in 1993 to take advantage of the technical advancements and business evolution brought about by emerging technologies, Kronos builds solutions solely for pharmaceutical and biotech research. Integrating expertise in software development and communications has resulted in the delivery of the newest interactive data collection, analysis and dissemination.Today's challenge is to use technology...

B. McLaughlin Associates, Inc.

BMA is a niche provider of clinical research services based in West Chester, Pennsylvania and Phoenix, Arizona. Our services focus on Study Management, Regulatory and Financial Document Retrieval, Clinical Study Agreement/Per Patient Budget Negotiation, Informed Consent Review and Approval, Data Discrepancy Retrieval, and Regulatory Document Audits.

Lynkogen Inc.

Alteogen Inc. is a Korea-based biopharmaceutical company that focuses on the development and commercialization of novel biologics such as Antibody-dug conjugates, biobetters and biosimilars. Alteogen’s portfolio includes clinical-stage long-acting therapeutic proteins and next-generation ADC, developed by its proprietary NexPTM-fusion and NexMabTM pla...

The Drug & Device Development Co., Inc

The Drug & Device Development Co., Inc. founded in 1985, has expertise in the regulatory, clinical, quality and statistical aspects of drug, biologic, diagnostic, and medical device development. The DDD group consists of both full-time and part-time specialists. Each one is well experienced in one or more aspects of the drug, biologic and/or device approval process.The major focus of DDD's service...

Alteogen Inc.

Alteogen lnc. is a Korea-based biopharmaceutical company that focuses on the development and commercialization of novel biologics such as ADCs, biobetters and biosimilars. Alteogen’s portfolio includes clinical-stage long-acting therapeutic proteins and next-generation ADCs, developed by its proprietary NexPTM-fusion and NexMabTM ADC conjugation techn...

Arrowhead Publishers

Arrowhead Publishers is a leader in business intelligence and market research reports for the pharmaceutical and biotech industries. Our reports offer readers a blend of information, insight, analysis and forecasting that is essential in today’s ultra-competitive pharmaceutical and biotech markets. Arrowhead analysts draw upon the most up-to-date information and lend their industry expertise t...

Adamis Pharmaceuticals Corporation

La Jolla Pharmaceutical Company is a biopharmaceutical company. La Jolla had historically focused substantially all of its research, development and clinical efforts and financial resources toward the development of its Riquent® (abetimus sodium) product candidate, as a treatment for patients with lupus. In February 2009, La Jolla announced that an inde...

Business Insights Ltd.

Business Insights appreciate the importance of accurate, up-to-date incisive market and company analysis and our aim therefore is to provide a single, off-the-shelf, objective source of data, analysis and market insight. Business Insights work in association with leading industry experts to produce a range of reports across a wide range of industry sectors. By working in association with so many e...

Medisse BV

Medisse BV is a leading innovator and developer of synthetic resorbable soft tissue implants. The Company’s first product, FlexiSurge Adhesion Barrier, is currently tested in a clinical study to obtain the clinical data needed for CE marking early in 2015. Medisse is also developing anti-adhesive technologies for use on other implantable medical devices ...

Vela Laboratories

Vela Laboratories (Vela pharmazeutische Entwicklung und Laboranalytik GmbH) provides a broad portfolio of analytical methods for the preclinical and clinical development including studies in support of regulatory submissions and product release for Biopharmaceuticals and Biosimilars, including monoclonal antibodies and growth factors.

Genetic Analysis AS

Genetic Analysis has developed and launched the first gene-based routine test for the mapping and diagnosis of diseases related to dysbiosis and imbalances in the digestive system. The company markets the GA-map™ technology to three market segments: commercial routine testing, pharma companies and the research market. Genetic Analysis was established ...

Pharmacon Research GmbH

Pharmacon Research is an independent contract research organization (CRO) with headquarters in Berlin and clinical sites in Prague, Warsaw, Bratislava and Budapest. Founded in 1992 by the management of a successful Phase I unit, Pharmacon Research focuses on specific Phase I studies in patients and symptomatic subjects and on early Phase II studies (dose finding, proof of concept). Irrespective of...

Genetic Analysis

Genetic Analysis has developed and launched the first gene-based routine test for the mapping and diagnosis of diseases related to dysbiosis and imbalances in the bacteria in the digestive system. The company markets the GA-map™ technology to three market segments: commercial routine testing, pharma companies and the research market. Genetic Analysis ...

Adello Biologics, LLC

Adello is a privately held, U.S.-based biotechnology company headquartered in Piscataway, NJ. The company's aim is to provide high-quality, affordable biosimilars to patients worldwide. Driven by a team of highly skilled industry veterans, Adello is advancing a pipeline of complex proteins and monoclonal antibodies with lead candidates in oncology and immu...

Expression Analysis

Expression Analysis was incorporated in September of 2001 specifically to fill the market need for a high quality supplier of microarray services and solutions. In October of 2001, Expression Analysis gained Duke University as its first customer. Duke University chose to close its Affymetrix core facility to take advantage of quality, cost and throughput improvements offered by Expression Analysis...

MVA Scientific Consultants

The scientific challenges facing today’s businesses and organizations are diverse and complex. Environmental concerns, legal and regulatory issues, increased operating performance and customer expectations are just some of the issues where science can impact the way business is done.MVA Scientific Consultants helps to meet some of these challenges by providing critical analysis and support ...

Intracel

Intracel is a leading commercial-stage biotechnology company focused on the development of immune therapy to treat cancer. The company’s pipeline includes product development programs in active immunotherapy and fully human monoclonal antibodies. Intracel has completed clinical studies in Colon, Renal and Ovarian carcinoma, as well as Melanoma. Business StrategyRestructured company to focus o...

ECRON

ECRON has unified national expertise under the roof of common SOP and a central project management.To guarantee success in your international projects we make use of our established local structures, grown relationships and our up-to-date knowledge about legal and regulatory framework

PANATecs GmbH

"PANATecs GmbH is a Service Company offering complex peptide synthesis services and comprehensive mass spectrometry-based analytical services for peptides, proteins and biosimilars extended characterisation, biocomparability analysis, etc. In addition we are synthesis specialists for complex peptides up to 80aa in a range of 1 to more than 100mg."


More From BioPortfolio on "BIOSIMILARS Market Study Regulatory Framework Pipeline Analysis 2015"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks